Karl Handelsman Overview

  • Investor Type
  • Angel
  • Status
  • Active
  • Professionals
  • 1
Professionals
  • Investments
  • 20
  • Portfolio
  • 8
  • Exits
  • 13
Exits

Karl Handelsman General Information

Description

Mr. Karl Handelsman is a Founder of Codon Capital. He also served as Senior Advisor at Roche Venture Fund, and as a Board Member at Good Therapeutics. He is a seasoned venture capitalist with 20 years of experience investing in early stage biotechnology (therapeutics and synthetic biology), working with entrepreneurs from idea to IPO as a trusted advisor and BoD member. He received advanced degrees from MIT (MBA) and Harvard Medical School (MS/Genetics) and then worked in Business Development (Tularik, Millenium). He founded Codon Capital after 14 years as a managing director at CMEA Ventures. Codon Capital is based in San Francisco, Ca.

Contact Information

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • San Francisco, CA
  • United States

Karl Handelsman Investments (20)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Good (Drug Discovery) 07-May-2020 Early Stage VC 000.00 Drug Discovery Generating Revenue 0000 0000000000
0000000 26-May-2017 00000 00000 00.000 Drug Discovery Product Development 0000 0000000000
000000000 00000000 02-May-2016 00000 00000 00.000 Drug Discovery Generating Revenue 0000 0000000000
00000 000 22-Mar-2016 00000 00000 0000 Agricultural Chemicals Generating Revenue 0000 0000000000
000000 01-Dec-2015 00000 (00000 00000 Drug Discovery Generating Revenue/Not Profitable 0000 0000000000
00000000000 01-Oct-2015 00000 00000 00000 Drug Discovery Generating Revenue 0000 0000000000
0000 0000000000000 01-Dec-2014 00000 00000 0000 Drug Discovery Generating Revenue 0000 0000000000
00000000 000000000 01-May-2014 0000 00000 00000 Application Software Startup 0000 0000000000
Amplyx Pharmaceuticals 01-Jan-2011 Early Stage VC 00.00 Drug Discovery Generating Revenue 0000 0000000000
Gust 01-Jan-2004 Early Stage VC Financial Software Generating Revenue 0000 0000000000
You’re viewing 10 of 20 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Karl Handelsman Exits (13)

Company Name Exit Date Exit Type Exit Size
Caribou Biosciences 23-Jul-2021 IPO 00000
000000 00000000000 28-Apr-2021 000000000000000000
0000000 0000000000 12-Jun-2020 000 00000
0000 0000000000000 24-Apr-2020 000 00000
0000 000000000000 01-Nov-2019 000 0000
00000000 17-Jul-2018 000000000000000000 000
0000 00000000 28-Jun-2018 000000 0000000000 0000
00000 00000000000 15-Mar-2018 000 00000
Zephyrus Biosciences 14-Mar-2016 Merger/Acquisition 0000
Glycostasis 01-Dec-2015 Merger/Acquisition
You’re viewing 10 of 13 exits. Get the full list »

Karl Handelsman Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Karl Handelsman Team (1)

Name Title Deals Funds Boards Office
Karl Handelsman Angel Investor 00 0 0 San Francisco, CA
To view Karl Handelsman’s complete team members history, request access »

Karl Handelsman Co-Investors (11)

Name With Exits Lead Partner Series Industry
Codon Capital 2 0 Series chart Industry bar
3x5 Partners 0 0 Series chart Industry bar
RiverVest Venture Partners 0 0 Series chart Industry bar
Roche Venture Fund 0 0 Series chart Industry bar
Sherpalo Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 11 co-investors. Get the full list »